Literature DB >> 1993457

Inflammatory status and preerythrocytic stages of malaria: role of the C-reactive protein.

A Nussler1, S Pied, M Pontet, F Miltgen, L Renia, M Gentilini, D Mazier.   

Abstract

In the acquisition of protection against malaria, the role played by nonspecific factors, some being part of the cascade effect of cytokines, has to be considered. The C-reactive protein, a major acute phase reactant secreted by interleukin-1 stimulated hepatocytes, has an effect on the hepatic development of Plasmodia, both by preventing penetration of the sporozoite into the hepatocyte and by blocking parasite division through an antibody-like effect. This latter effect confirms the potential interest of targeting the uninuclear form of the parasite. Nevertheless, C-reactive Protein alone does not account for all the effects of the inflammatory response, other reactants from both serum and hepatocytes are also involved.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993457     DOI: 10.1016/0014-4894(91)90114-c

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

1.  Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.

Authors:  R Harpaz; R Edelman; S S Wasserman; M M Levine; J R Davis; M B Sztein
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide.

Authors:  L Rénia; M S Marussig; D Grillot; S Pied; G Corradin; F Miltgen; G Del Giudice; D Mazier
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.

Authors:  Preeyaporn Monatrakul; Mathirut Mungthin; Arjen M Dondorp; Srivicha Krudsood; Rachanee Udomsangpetch; Polrat Wilairatana; Nicholas J White; Kesinee Chotivanich
Journal:  Malar J       Date:  2010-11-16       Impact factor: 2.979

4.  Transgenic mice expressing C-reactive protein are susceptible to infection with Plasmodium yoelii sporozoites.

Authors:  L Rénia; D Xia; D Samols; V Nussenzweig
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

5.  Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin.

Authors:  S Mellouk; S L Hoffman; Z Z Liu; P de la Vega; T R Billiar; A K Nussler
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

6.  Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations.

Authors:  Nadya Depinay; Jean Francois Franetich; Anne Charlotte Grüner; Marjorie Mauduit; Jean-Marc Chavatte; Adrian J F Luty; Geert-Jan van Gemert; Robert W Sauerwein; Jean-Michel Siksik; Laurent Hannoun; Dominique Mazier; Georges Snounou; Laurent Rénia
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

7.  Identification of protein markers in patients infected with Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax.

Authors:  Alan Kang-Wai Mu; Ping Chong Bee; Yee Ling Lau; Yeng Chen
Journal:  Int J Mol Sci       Date:  2014-11-03       Impact factor: 5.923

Review 8.  C-Reactive Protein: Friend or Foe? Phylogeny From Heavy Metals to Modified Lipoproteins and SARS-CoV-2.

Authors:  Michael Torzewski
Journal:  Front Cardiovasc Med       Date:  2022-03-24

9.  Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria.

Authors:  Julie Bachmann; Florence Burté; Setia Pramana; Ianina Conte; Biobele J Brown; Adebola E Orimadegun; Wasiu A Ajetunmobi; Nathaniel K Afolabi; Francis Akinkunmi; Samuel Omokhodion; Felix O Akinbami; Wuraola A Shokunbi; Caroline Kampf; Yudi Pawitan; Mathias Uhlén; Olugbemiro Sodeinde; Jochen M Schwenk; Mats Wahlgren; Delmiro Fernandez-Reyes; Peter Nilsson
Journal:  PLoS Pathog       Date:  2014-04-17       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.